Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Arizona
1113
mi
from 98109
Scottsdale, AZ
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Arizona
1113
mi
from 98109
Scottsdale, AZ
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Florida
2462
mi
from 98109
Jacksonville, FL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Florida
2462
mi
from 98109
Jacksonville, FL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Rush - Copley Medical Center
1704
mi
from 98109
Aurora, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Rush - Copley Medical Center
1704
mi
from 98109
Aurora, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Bloomington
1714
mi
from 98109
Bloomington, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Bloomington
1714
mi
from 98109
Bloomington, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Graham Hospital Association
1662
mi
from 98109
Canton, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Graham Hospital Association
1662
mi
from 98109
Canton, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Canton
1662
mi
from 98109
Canton, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Canton
1662
mi
from 98109
Canton, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Memorial Hospital
1616
mi
from 98109
Carthage, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Memorial Hospital
1616
mi
from 98109
Carthage, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Carthage
1616
mi
from 98109
Carthage, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Carthage
1616
mi
from 98109
Carthage, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
1730
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Anthony Memorial Hospital
1780
mi
from 98109
Effingham, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Anthony Memorial Hospital
1780
mi
from 98109
Effingham, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Eureka Hospital
1692
mi
from 98109
Eureka, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Eureka Hospital
1692
mi
from 98109
Eureka, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Eureka
1692
mi
from 98109
Eureka, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Eureka
1692
mi
from 98109
Eureka, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Galesburg Cottage Hospital
1634
mi
from 98109
Galesburg, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Galesburg Cottage Hospital
1634
mi
from 98109
Galesburg, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Havana
1669
mi
from 98109
Havana, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Havana
1669
mi
from 98109
Havana, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mason District Hospital
1669
mi
from 98109
Havana, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mason District Hospital
1669
mi
from 98109
Havana, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Hopedale Medical Complex - Hospital
1695
mi
from 98109
Hopedale, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Hopedale Medical Complex - Hospital
1695
mi
from 98109
Hopedale, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Joliet Oncology-Hematology Associates Limited
1722
mi
from 98109
Joliet, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Joliet Oncology-Hematology Associates Limited
1722
mi
from 98109
Joliet, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Kewanee Clinic
1645
mi
from 98109
Kewanee, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Kewanee Clinic
1645
mi
from 98109
Kewanee, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Kewanee Hospital
1646
mi
from 98109
Kewanee, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Kewanee Hospital
1646
mi
from 98109
Kewanee, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Macomb
1636
mi
from 98109
Macomb, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Macomb
1636
mi
from 98109
Macomb, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
McDonough District Hospital
1636
mi
from 98109
Macomb, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
McDonough District Hospital
1636
mi
from 98109
Macomb, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Monmouth
1622
mi
from 98109
Monmouth, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Monmouth
1622
mi
from 98109
Monmouth, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Holy Family Medical Center
1622
mi
from 98109
Monmouth, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Holy Family Medical Center
1622
mi
from 98109
Monmouth, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
BroMenn Regional Medical Center
1712
mi
from 98109
Normal, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
BroMenn Regional Medical Center
1712
mi
from 98109
Normal, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Community Cancer Center
1712
mi
from 98109
Normal, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Community Cancer Center
1712
mi
from 98109
Normal, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Ottawa Clinic
1692
mi
from 98109
Ottawa, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Ottawa Clinic
1692
mi
from 98109
Ottawa, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Pekin Hospital
1679
mi
from 98109
Pekin, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Pekin Hospital
1679
mi
from 98109
Pekin, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Pekin
1678
mi
from 98109
Pekin, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Pekin
1678
mi
from 98109
Pekin, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Peoria
1678
mi
from 98109
Peoria, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Peoria
1678
mi
from 98109
Peoria, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Proctor Hospital
1676
mi
from 98109
Peoria, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Proctor Hospital
1676
mi
from 98109
Peoria, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare-Peoria
1678
mi
from 98109
Peoria, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare-Peoria
1678
mi
from 98109
Peoria, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Methodist Medical Center of Illinois
1678
mi
from 98109
Peoria, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Methodist Medical Center of Illinois
1678
mi
from 98109
Peoria, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Peru
1679
mi
from 98109
Peru, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Peru
1679
mi
from 98109
Peru, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Perry Memorial Hospital
1664
mi
from 98109
Princeton, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Perry Memorial Hospital
1664
mi
from 98109
Princeton, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Princeton
1664
mi
from 98109
Princeton, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Princeton
1664
mi
from 98109
Princeton, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Saint Margaret's Hospital
1676
mi
from 98109
Spring Valley, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Saint Margaret's Hospital
1676
mi
from 98109
Spring Valley, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Illinois CancerCare - Spring Valley
1676
mi
from 98109
Spring Valley, IL
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Illinois CancerCare - Spring Valley
1676
mi
from 98109
Spring Valley, IL
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center - Des Moines
1463
mi
from 98109
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center - Des Moines
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Iowa Methodist Medical Center
1463
mi
from 98109
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Iowa Methodist Medical Center
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Capitol
1463
mi
from 98109
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Capitol
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Iowa Lutheran Hospital
1463
mi
from 98109
Des Moines, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Iowa Lutheran Hospital
1463
mi
from 98109
Des Moines, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center - North Iowa
1438
mi
from 98109
Mason City, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center - North Iowa
1438
mi
from 98109
Mason City, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Mercy Medical Center - Sioux City
1306
mi
from 98109
Sioux City, IA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Mercy Medical Center - Sioux City
1306
mi
from 98109
Sioux City, IA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Hospital District Sixth of Harper County
1427
mi
from 98109
Anthony, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Hospital District Sixth of Harper County
1427
mi
from 98109
Anthony, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Chanute
1519
mi
from 98109
Chanute, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Chanute
1519
mi
from 98109
Chanute, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Dodge City
1315
mi
from 98109
Dodge City, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Dodge City
1315
mi
from 98109
Dodge City, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - El Dorado
1451
mi
from 98109
El Dorado, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - El Dorado
1451
mi
from 98109
El Dorado, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas - Fort Scott
1545
mi
from 98109
Fort Scott, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas - Fort Scott
1545
mi
from 98109
Fort Scott, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas-Independence
1525
mi
from 98109
Independence, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas-Independence
1525
mi
from 98109
Independence, KA
Click here to add this to my saved trials
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated:  12/31/1969
Cancer Center of Kansas, PA - Kingman
1404
mi
from 98109
Kingman, KA
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
A Phase I/II Trial of Sorafenib and CCI-779 in Patients With Recurrent Glioblastoma
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Kansas, PA - Kingman
1404
mi
from 98109
Kingman, KA
Click here to add this to my saved trials